オプション
家 AIプロンプト一覧 医療健康 処方箋審査アシスタント

処方箋審査アシスタント

{:__('collect %s',処方箋審査アシスタント)}

AI技術を活用し、薬剤師の調剤前審査を支援し、潜在的な薬物相互作用、用量異常、禁忌症を特定し、投薬の安全性と効率を向上させます。

プロンプト内容 コピー コピー

Act as a senior clinical pharmacist and review the following simulated prescription: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and Ibuprofen 400mg tid (for osteoarthritis pain). Analyze if there are drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the risks of NSAID use in patients with renal impairment, and provide specific adjustment suggestions or alternative plans to ensure medication safety and compliance with clinical guidelines.

コピー コピー

シニア臨床薬剤師として、以下の模擬処方箋を審査してください。患者は65歳の男性で、高血圧2級および軽度の腎機能障害(eGFR 45ml/min)と診断されています。現在の投与薬は、アムロジピン5mg qd、アスピリン100mg qd、およびイブプロフェン400mg tid(骨関節炎の痛み用)です。薬物-疾患の禁忌、薬物-薬物相互作用、または用量調整の必要性がないか分析し、特に腎機能障害患者におけるNSAIDs使用のリスクに焦点を当て、具体的な調整提案または代替案を提供し、投薬の安全性と臨床ガイドラインへの準拠を確保してください。

コピー コピー
コメント (0)
0/300

おすすめ

処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all drug names with dosages. Second, cross-reference these details against the latest clinical guidelines and package inserts to check for contraindications, drug-drug interactions, or dosage errors. Finally, if any safety risks are identified, clearly specify the risk and provide evidence-based adjustment suggestions or alternative therapies to support clinical decision-making.
処方箋審査アシスタント
Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and a newly prescribed Ibuprofen 400mg three times daily for joint pain. Analyze whether this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, particularly regarding the risk of using non-steroidal anti-inflammatory drugs in patients with renal insufficiency, and provide specific adjustment suggestions or alternative solutions to ensure medication safety.
処方箋審査アシスタント
Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 Hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and a newly prescribed Ibuprofen 400mg tid. Analyze if this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the impact of NSAIDs on renal function and the combined risk with antiplatelet agents, and provide specific adjustment suggestions or warning information to ensure the safety and efficacy of the medication regimen.
処方箋審査アシスタント
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness, while flagging any risks according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations.
処方箋審査アシスタント
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and whether the dosage aligns with the patient's hepatic and renal function status. Identify any risk points based on the latest clinical guidelines, and finally provide adjustment suggestions or confirm safety, ensuring the output is concise and clinically actionable.
処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions to ensure patient safety.
OR